Abstract
Antiangiogenic therapy has been proposed as a new strategy for the treatment of solid tumors. To enhance the therapeutic effect of antiangiogenic agents, combination with conventional anticancer therapy should be investigated. In the present study, we investigated the therapeutic effect of the combination of vascular endothelial growth factor neutralizing antibody (VEGF Ab) and mitomycin C (MMC) on MT‐2, a human gastric cancer xenograft. When small pieces of MT‐2 were transplanted orthotopically into 62 nude mice, liver metastasis developed 6 weeks after transplantation. The VEGF Ab (100 μg/mouse) was administered i.p. in the VEGF Ab group (n=14) and the combination group (n=16) twice a week from day 10 after transplantation. MMC (2 mg/kg) was administered in the MMC group (n=16) and the combination group (n=16) on days 10, 17 and 24 after transplantation. Compared with the control group, in which saline solution was administered i.p., all three treatments inhibited tumor growth significantly and the effects of MMC and combination therapy were potent. Liver metastases were also inhibited significantly by the administration of VEGF Ab alone, MMC alone or combination therapy. Liver metastasis developed in 9 mice of the control group, 3 of the VEGF Ab group, and 4 of the MMC group, but no mice had liver metastasis in the combination therapy group. However a significant body weight loss and a decrease in spleen weight were observed in the MMC and combination groups, with no significant difference between the two groups. These results suggest that combination therapy with VEGF Ab and MMC may be a potent therapy for human gastric cancer.
Keywords: Gastric cancer, VEGF neutralizing antibody, Mitomycin C, Liver metastasis, Combination
Full Text
The Full Text of this article is available as a PDF (889.0 KB).
REFERENCES
- 1. ) Folkman , J.What is the evidence that tumors are angiogenesis dependent? [editorial] . J. Natl. Cancer Inst. , 82 , 4 – 6 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Ferrara , N. , Houck , K. , Jakeman , L. and Leung , D. W.Molecular and biological properties of the vascular‐endothelial‐growth‐factor family of proteins . Endocr. Rev. , 13 , 18 – 32 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Kondo , S. , Asano , M. and Suzuki , H.Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody . Biochem. Biophys. Res. Commun. , 194 , 1234 – 1241 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Brown , L. F. , Berse , B. , Jackman , R. W. , Tognazzi , K. , Manseau , E. J. , Senger , D. R. and Dvorak , H. F.Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract . Cancer Res. , 53 , 4727 – 4735 ( 1993. ). [PubMed] [Google Scholar]
- 5. ) Toi , M. , Inada , K. , Suzuki , H. and Tominaga , T.Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression . Breast Cancer Res. Treat. , 36 , 193 – 204 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Takahashi , Y. , Kitadai , Y. , Bucana , C. D. , Cleary , K. R. and Ellis , L. M.Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer . Cancer Res. , 55 , 3964 – 3968 ( 1995. ). [PubMed] [Google Scholar]
- 7. ) Maeda , K. , Chung , Y. S. , Ogawa , Y. , Takatsuka , S. , Kang , S. M. , Ogawa , M. , Sawada , T. and Sowa , M.Prognostic value of vascular‐endothelial‐growth‐factor expression in gastric carcinoma . Cancer , 77 , 858 – 863 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Kim , K. J. , Li , B. , Winer , J. , Armanini , M. , Gillett , N. , Phillips , H. S. and Ferrara , N.Inhibition of vascular endothelial growth factor‐induced angiogenesis suppresses tumor growth in vivo . Nature , 362 , 841 – 844 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Warren , R. S. , Yuan , H. , Matli , M. R. , Gillett , N. A. and Ferrara , N.Regulation by vascular endothelial growth factor of human colon‐cancer tumorigenesis in a mouse model of experimental liver metastasis . J. Clin. Invest. , 95 , 1789 – 1797 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. ) Asano , M. , Yukita , A. , Matsumoto , T. , Kondo , S. and Suzuki , H.Inhibition of tumor growth and metastasis by immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121 . Cancer Res. , 55 , 5296 – 5301 ( 1995. ). [PubMed] [Google Scholar]
- 11. ) Kanai , T. , Konno , H. , Tanaka , T. , Baba , M. , Matsumoto , K. , Nakamura , S. , Yukita , A. , Asano , M. , Suzuki , H. and Baba , S.Anti‐tumor and anti‐metastatic effects of humanvascular‐endothelial‐growth‐factor‐neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice . Int. J. Cancer , 77 , 933 – 936 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Asano , M. , Yukita , A. , Matsumoto , H. , Hanatani , M. and Suzuki , H.An anti‐human VEGF monoclonal antibody, MV833, that exhibits potent anti‐tumor activity in vivo . Hybridoma , 17 , 185 – 190 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Fu , X. , Bersterman , J. M. , Monosov , A. and Hoffman , R. M.Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens . Proc. Natl. Acad. Sci. USA , 88 , 9345 – 9349 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. ) Kamiya , K. , Konno , H. , Tanaka , T. , Baba , M. , Matsumoto , K. , Sakaguchi , T. , Yukita , A. , Asano , M. , Suzuki , H. , Arai , T. and Nakamura , S.Antitumor effect on human gastric cancer and induction of apoptosis by vascular endothelial growth factor neutralizing antibody . Jpn. J. Cancer Res. , 90 , 794 – 800 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. ) Furukawa , T. , Fu , X. , Kubota , T. , Watanabe , M. , Kitajima , M. and Hoffman , R. M.Nude‐mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue . Cancer Res. , 53 , 1204 – 1208 ( 1993. ). [PubMed] [Google Scholar]
- 16. ) Millauer , B. , Shawver , L. K. , Plate , K. H. , Risau , W. and Ullrich , A.Glioblastoma growth inhibited in vivo by a dominant‐negative Flk‐1 mutant . Nature , 367 , 576 – 579 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Melnyk , O. , Shuman , M. A. and Kim , K. J.Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth . Cancer Res. , 56 , 921 – 924 ( 1996. ). [PubMed] [Google Scholar]
- 18. ) Konno , H. , Tanaka , T. , Matsuda , I. , Kanai , T. , Maruo , Y. , Nishino , N. , Nakamura , S. and Baba , S.Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP‐470, and Mitomycin C on the growth and liver metastasis of human colon cancer . Int. J. Cancer , 61 , 268 – 271 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 19. ) Borgstrom , P. , Hillan , K. J. , Sriramarao , P. and Ferrara , N.Complete inhibition of angiogenesis and growth of microtumors by anti‐vascular endothelial growth factor neutralizing antibody : novel concepts of angiostatic therapy from intravital videomicroscopy . Cancer Res. , 56 , 4032 – 4039 ( 1996. ). [PubMed] [Google Scholar]
- 20. ) Kakeji , Y. , Maehara , Y. , Ikebe , M. and Teicher , B. A.Dynamics of tumor oxygenation, CD31 staining and transforming growth factor‐beta levels after treatment with radiation or cyclophosphamide in the rat 13762 mammary carcinoma . Int. J. Radiat. Oncol. Biol. Phys. , 37 , 1115 – 1123 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 21. ) Kuo , T. S. , Kubota , T. , Watanabe , M. , Furukawa , T. , Teramoto , T. , Ishibiki , K. , Kitajima , M. and Hoffman , R. M.Early resection of primary orthotopically growing human colon tumor in nude mouse prevents liver metastasis: further evidence for patient‐like hematogenous metastatic route . Anticancer Res. , 13 , 293 – 298 ( 1993. ). [PubMed] [Google Scholar]